RAPID
Research in Applied Pharmacokinetics and Individualised Dosing
Research in Applied Pharmacokinetics and Individualised Dosing
We apply pharmacokinetics, pharmacometrics, and pharmacogenetics to support individualised dosing and clinical decision-making in Malaysia and beyond.
These are our ongoing project areas — but we are open to collaboration in any therapeutic area.
Anticoagulants, exposure variability, and precision dosing.
PK-guided therapy, toxicity risk, and dosing optimisation.
Model-informed antimicrobial dosing in complex patients.
Population PK, PKPD, and pharmacometric modelling to understand variability, predict exposure, and support dose optimisation.
Model-informed decisions grounded in real clinical data.
Integrating genetic and non-genetic factors to explain inter-individual variability in drug exposure and response.
Translating genotype into clinically meaningful dosing insights.
Quantification of drug concentrations and biomarkers using validated HPLC and coagulation assays.
Linking measured exposure to models and clinical outcomes.
We run a journal club once a month focused on PK/PD, modelling, and precision dosing.
Clinical research support, modelling, PGx integration, and translational study design.